WHO ICTRP trial
MEG in Alzheimer's Disease: unravelling the underlying network to explain the…
NL-OMON48723 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON48723 |
|---|---|
| Public title | MEG in Alzheimer's Disease: unravelling the underlying network to explain the stereotypical spread of Tau protein |
| Scientific title | MEG in Alzheimer's Disease: unravelling the underlying network to explain the stereotypical spread of Tau protein - MANTA |
| Primary sponsor | Vrije Universiteit Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Countries | The Netherlands |
| Conditions | cognitive impairment Dementia;10014623;10012272;cognitive impairment;Dementia |
| Interventions | ;Brain Networks;Dementia;Functional connectivity;Tau protein |
| Registration date | Nov 14, 2019 |
| Target size | 180 |
| Secondary IDs | NL64638.029.18 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: